Let’s Talk
Linkedin
Let’s Talk
Linkedin

Tailor-made to individual organizational needs

We are specialized in pharma pricing and knows the best practices for tools, processes and strategies. We always leverage our deep experience to deliver value.

Optimize your pricing today

Tailor-made to individual organizational needs

We are specialized in pharma pricing and knows the best practices for tools, processes and strategies. We always leverage our deep experience to deliver value.

Optimize your pricing today

Strategic Pricing Consulting

Pricing strategies that will deliver optimal value along the product life cycle

  • Launch Pricing strategy
  • Life Cycle Management strategy
  • Loss of Exclusivity strategy
  • Contracting and Gross to Net strategy
  • Commercial net price optimization
  • Licensing evaluation
  • Pricing maturity assessment
  • Organizational design & related processes

Market Access Consulting

Support both strategic and operational pricing with market access deliverables

  • Payer landscaping
  • Early health economic assessment
  • Payer strategy
  • HEOR strategy & study design
  • Post-launch value optimisation

Turnkey Pricing Tools

Leverage pharma-built, effective and user-friendly tools to strengthen your pricing capabilities

  • Atlas360: Complete Microsoft-based Pricing & Access Software System
  • Hercules: Advanced and fast IRP & LSO tool
  • Payer Value Based Agreement modelling
  • Integrated Pricing & Access
  • Tools & Systems


All tools have a short implementation timeline.

Operational Pricing Solutions

Optimize operational pricing deliverables and gain efficiencies

  • Pricing as a Service (PaaS)
  • Outsourcing of all or some activities
  • IRP management, processes and systems
  • Price requests & certificates

Strategic Pricing Consulting

Pricing strategies that will deliver optimal value along the product life cycle

  • Launch Pricing strategy
  • Life Cycle Management strategy
  • Loss of Exclusivity strategy
  • Contracting and Gross to Net strategy
  • Commercial net price optimization
  • Licensing evaluation
  • Pricing maturity assessment
  • Organizational design & related processes

Market Access Consulting

Support both strategic and operational pricing with market access deliverables

  • Payer landscaping
  • Early health economic assessment
  • Payer strategy
  • HEOR strategy & study design
  • Post-launch value optimisation

Turnkey Pricing Tools

Leverage pharma-built, effective and user-friendly tools to strengthen your pricing capabilities

  • Atlas360: Complete Microsoft-based Pricing & Access Software System
  • Hercules: Advanced and fast IRP & LSO tool
  • Payer Value Based Agreement modelling
  • Integrated Pricing & Access
  • Tools & Systems


All tools have a short implementation timeline.

Operational Pricing Solutions

Optimize operational pricing deliverables and gain efficiencies

  • Pricing as a Service (PaaS)
  • Outsourcing of all or some activities
  • IRP management, processes and systems
  • Price requests & certificates

Strategic Pricing Consulting

Pricing strategies that will deliver optimal value along the product life cycle

  • Launch Pricing strategy
  • Life Cycle Management strategy
  • Loss of Exclusivity strategy
  • Contracting and Gross to Net strategy
  • Commercial net price optimization
  • Licensing evaluation
  • Pricing maturity assessment
  • Organizational design & related processes

Market Access Consulting

Support both strategic and operational pricing with market access deliverables

  • Payer landscaping
  • Early health economic assessment
  • Payer strategy
  • HEOR strategy & study design
  • Post-launch value optimisation

Turnkey Pricing Tools

Leverage pharma-built, effective and user-friendly tools to strengthen your pricing capabilities

  • Atlas360: Complete Microsoft-based Pricing & Access Software System
  • Hercules: Advanced and fast IRP & LSO tool
  • Payer Value Based Agreement modelling
  • Integrated Pricing & Access
  • Tools & Systems


All tools have a short implementation timeline.

Operational Pricing Solutions

Optimize operational pricing deliverables and gain efficiencies

  • Pricing as a Service (PaaS)
  • Outsourcing of all or some activities
  • IRP management, processes and systems
  • Price requests & certificates

Working with Pricia means gaining a partner who is personally invested in your success, not just delivering a service.

Why Clients Trust Pricia
At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver.

We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality.

Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.

Working with Pricia means gaining a partner who is personally invested in your success, not just delivering a service.

Why Clients Trust Pricia
At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver.

We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality.

Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.

CLIENT TESTIMONIALS

“Established full organizational and structural setup for the pricing analytics department – including full stakeholder involvement. Led to fast integration earlier than planned”
Top 10 Pharma company
“Review, build and recommend an effective price certificate process including full stakeholder involvement.”
Mid-sized Pharma company
“Optimization of a portfolio of mature products in select emerging markets.”
Top 10 Pharma company
“Development of full Global LoE Strategy for a soon to expire product. Identified a 5% profit optimization”
Mid-sized Pharma company
“It was a great pleasure working with Pricia, and we achieved some great things together. I truly appreciated the professionalism, sense of urgency, deep expertise and collaborative spirit demonstrated by all members of the Pricia team.”
Top 10 Pharma company
“We were looking to navigate the complexities of entering the U.S. market, specifically needing robust feasibility assessments and a clear market entry strategy. Understanding the competitive landscape and establishing a sound pricing structure were our primary challenges.”
Small European-based MedTech company
“Their professionalism, deep market knowledge, and the actionable nature of their insights truly stood out. Martin was highly responsive and delivered comprehensive, well-researched information that was immediately useful..”
SaMD MedTech company

Pricing & Payer Launch Strategy

  • Payer landscape assessment
  • Early health economic analysis
  • Payer evidence gap analysis
  • HEOR strategy & study design
  • Go-to-market model
  • Indication & launch sequencing
  • Launch pricing strategy
  • Asset value assessment

HTA / Reimbursement Submissions

  • Early HTA/payer advice
  • Payer advisory boards
  • Health economic model
  • Global value dossier
  • Stakeholder engagement
  • Submission support
  • Formulary access tools
  • Price requests & certificates

Life Cycle Management Strategy

  • Loss of exclusivity strategy
  • Pricing maturity assessment
  • Net price optimisation
  • Contracting strategy
  • Real-world evidence application
  • Local access optimisation
  • Gross-to-Net strategy
  • Price governance development

Pricing & Payer Launch Strategy

  • Payer landscape assessment
  • Early health economic analysis
  • Payer evidence gap analysis
  • HEOR strategy & study design
  • Go-to-market model
  • Indication & launch sequencing
  • Launch pricing strategy
  • Asset value assessment

HTA / Reimbursement Submissions

  • Early HTA/payer advice
  • Payer advisory boards
  • Health economic model
  • Global value dossier
  • Stakeholder engagement
  • Submission support
  • Formulary access tools
  • Price requests & certificates

Life Cycle Management Strategy

  • Loss of exclusivity strategy
  • Pricing maturity assessment
  • Net price optimisation
  • Contracting strategy
  • Real-world evidence application
  • Local access optimisation
  • Gross-to-Net strategy
  • Price governance development

End-To-End Market Access and Pricing Consulting

Pricing is a continuous balance between product cost and payer outcomes
– It starts strategic, then becomes dynamic and operational. 

How We Support the Full Product Lifecycle

This graph illustrates the strategic support Pricia provides across the entire product lifecycle.

  • In the early life science phases, we guide clients through Pricing and Payer Launch Strategy, including payer landscape assessment, early health economic analysis, evidence gap identification and go-to-market planning.
  • As products approach launch and market introduction, we support HTA and Reimbursement Submissions, helping clients prepare global value dossiers, engage with stakeholders and navigate the submission process.
  • In the growth, maturity and decline stages, we provide Life Cycle Management Strategy, including loss of exclusivity planning, contracting and net price optimisation, local access support and the strategic use of real-world evidence.


The result is end-to-end alignment of pricing, market access and payer engagement, ensuring clients are prepared not only for launch, but for long-term market success.

End-To-End Market Access and Pricing Consulting

Pricing is a continuous balance between product cost and payer outcomes
– It starts strategic, then becomes dynamic and operational. 

How We Support the Full Product Lifecycle

This graph illustrates the strategic support Pricia provides across the entire product lifecycle.

  • In the early life science phases, we guide clients through Pricing and Payer Launch Strategy, including payer landscape assessment, early health economic analysis, evidence gap identification and go-to-market planning.
  • As products approach launch and market introduction, we support HTA and Reimbursement Submissions, helping clients prepare global value dossiers, engage with stakeholders and navigate the submission process.
  • In the growth, maturity and decline stages, we provide Life Cycle Management Strategy, including loss of exclusivity planning, contracting and net price optimisation, local access support and the strategic use of real-world evidence.


The result is end-to-end alignment of pricing, market access and payer engagement, ensuring clients are prepared not only for launch, but for long-term market success.

Working with Pricia means gaining a partner who is personally invested in your success, not just delivering a service.

Why Clients Trust Pricia
At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver.

We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality.

Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.

"The U.S. focus on Most-Favored Nation (MFN) pricing will impact global pricing dynamics, despite strong interests both supporting and opposing such changes. This increases the importance of strategic pricing."

Paw Trebbien
Pricia CEO

Pricing & Payer Launch Strategy

  • Payer landscape assessment
  • Early health economic analysis
  • Payer evidence gap analysis
  • HEOR strategy & study design
  • Go-to-market model
  • Indication & launch sequencing
  • Launch pricing strategy
  • Asset value assessment

HTA / Reimbursement Submissions

  • Early HTA/payer advice
  • Payer advisory boards
  • Health economic model
  • Global value dossier
  • Stakeholder engagement
  • Submission support
  • Formulary access tools
  • Price requests & certificates

Life Cycle Management Strategy

  • Loss of exclusivity strategy
  • Pricing maturity assessment
  • Net price optimisation
  • Contracting strategy
  • Real-world evidence application
  • Local access optimisation
  • Gross-to-Net strategy
  • Price governance development

End-To-End Market Access and Pricing Consulting

Pricing is a continuous balance between product cost and payer outcomes
– It starts strategic, then becomes dynamic and operational. 

How We Support the Full Product Lifecycle

This graph illustrates the strategic support Pricia provides across the entire product lifecycle.

  • In the early life science phases, we guide clients through Pricing and Payer Launch Strategy, including payer landscape assessment, early health economic analysis, evidence gap identification and go-to-market planning.
  • As products approach launch and market introduction, we support HTA and Reimbursement Submissions, helping clients prepare global value dossiers, engage with stakeholders and navigate the submission process.
  • In the growth, maturity and decline stages, we provide Life Cycle Management Strategy, including loss of exclusivity planning, contracting and net price optimisation, local access support and the strategic use of real-world evidence.


The result is end-to-end alignment of pricing, market access and payer engagement, ensuring clients are prepared not only for launch, but for long-term market success.

The health care pricing landscape is changing

"The U.S. focus on Most-Favored Nation (MFN) pricing will impact global pricing dynamics, despite strong interests both supporting and opposing such changes. This increases the importance of strategic pricing."

Paw Trebbien
Pricia CEO

Ready to talk?
We're ready to listen.

Whether you’re developing your product, planning a first launch, reevaluating your market access strategy or looking to optimize pricing operations, our team is ready to help. At Pricia, every project starts with a conversation — not a pitch.

Reach out to discuss your needs and learn how we tailor solutions that deliver results.

Use our contact form to connect directly with the Pricia team. You can expect a response within one business day.

Ready to talk?
We're ready to listen.

Whether you’re developing your product, planning a first launch, reevaluating your market access strategy or looking to optimize pricing operations, our team is ready to help. At Pricia, every project starts with a conversation — not a pitch.

Reach out to discuss your needs and learn how we tailor solutions that deliver results.

Use our contact form to connect directly with the Pricia team. You can expect a response within one business day.

Ready to talk?
We're ready to listen.

Whether you’re developing your product, planning a first launch, reevaluating your market access strategy or looking to optimize pricing operations, our team is ready to help. At Pricia, every project starts with a conversation — not a pitch.

Reach out to discuss your needs and learn how we tailor solutions that deliver results.

Use our contact form to connect directly with the Pricia team. You can expect a response within one business day.